Figure 5. Serum creatine kinase (CK; U/L) in the experimental periods. CK prior to treatment (baseline) and after the start of treatment at 24, 48, 72, and 96 hours, creatine (CR) and placebo (PL) groups. * Indicates significant relative change between groups (p < 0.05). Values are means ± SD.